as well as specialty pumps such as insulin, patient-controlled analgesia, enteral, and implantable infusion pumps. The report ...
Insulet saw strong insulin pump adoption among new users with Type 2 diabetes following its recent FDA clearance, while ...
Like its peers, the impact of the present geopolitical situation may have curbed fiscal second-quarter profits for Medtronic.
VMPL New Delhi [India] November 7 Medtronic a global leader in healthcare technology unveiled results from the Prospective ...
Bernstein initiated coverage of Insulet (PODD) with an Outperform rating and $300 price target Innovation is driving accelerated insulin pump ...
Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its second quarter of fiscal ...
Baxter will share an update on Hurricane Helene’s impact, while Medtronic will likely discuss a new pulsed field ablation ...
PORTLAND, GA, UNITED STATES, November 5, 2024 /EINPresswire / -- The global Implantable Insulin Pump Market was pegged at $2.67 billion in 2020, and is estimated to reach $6.44 billion by 2030, ...